Navigation Links
Islamic Relief USA Signs Agreement with WHO to Provide Medicine to Libyan Cities
Date:7/29/2011

WASHINGTON, July 29, 2011 /PRNewswire-USNewswire/ -- Islamic Relief USA (IRUSA), a relief and development organization based in the D.C. metro area, has signed an agreement to support the World Health Organization's Project for Libya Crisis. IRUSA's contribution to the project will ensure patients' access to primary health care as well as trauma and injury care in Libya through supporting the deployment of external medical teams and provision of essential drugs, medical supplies and equipment to strengthen health care facilities and help rehabilitate health centers that are damaged.

Since violence broke out in Libya in February, Libyan hospitals have reported acute staffing shortages as the country's migrant health workers fled the violence. Moreover, supplies of essential drugs and medical supplies have since been alarmingly low. Health professionals and centers are overwhelmed as the number of those seeking health care for both war injuries and chronic illnesses continues to rise. According to the WHO, "the primary health care (PHC) network, which was already weak before the conflict, has collapsed in many areas."

Islamic Relief USA will support the deployment of nurses and expatriate Libyan experts to hospitals and health facilities in Benghazi and Misratah. In addition, Islamic Relief USA will fund provision of essential medications, medical supplies and ambulances to be sent to Benghazi and Tobruk.  "We know that an emergency response to Libya's health care crisis has been desperately needed. We are eager to collaborate with the World Health Organization to aid the most vulnerable during these tough times in Libya," said Abed Ayoub, IRUSA's CEO.

Since the start of conflict in Libya, Islamic Relief USA has undertaken various humanitarian projects to aid those affected by the violence, setting up and managing refugee camps on the borders with Tunisia. Currently, IRUSA's food distribution project in Tunisia supports 10,000 Libyan refugees in Tatouine and surrounding areas. Its Child Protection Program supports schooling and recreational activities for Libyan children at Remada Camp in Tunisia.

Islamic Relief USA is a nonprofit 501(c)(3)humanitarian organization with eight consecutive 4-star ratings from Charity Navigator. Its mission is to alleviate suffering, hunger, illiteracy and disease regardless of color, race, gender or creed, and to provide aid in a compassionate and dignified manner. Islamic Relief USA aims to provide rapid relief in the event of human and natural disasters and to establish sustainable local development projects, allowing communities to better help themselves.

MEDIA CONTACT: Asma Yousef, (703) 582-5880, ayousef@irusa.org


'/>"/>
SOURCE Islamic Relief USA
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Anesiva Initiates New Phase 2 Trial of Adlea(TM) for Pain Relief Following Knee Replacement Surgery
2. Anesiva Initiates Phase 2 Trial with Adlea(TM) for Pain Relief Following Total Hip Replacement Surgery
3. New Analysis of Study Data Shows That Asacol(R) (Mesalamine) Delivers Rapid Symptom Relief for Ulcerative Colitis Patients
4. Cost-Effectiveness Study Supports Use of EUFLEXXA(TM) by Rheumatologists for Pain Relief in Patients with Knee Osteoarthritis
5. FDA Approves XYZAL(R) (levocetirizine dihydrochloride) Oral Solution for the Relief of Seasonal and Year Round Allergies and Chronic Idiopathic Urticaria
6. Alexzas AZ-104 (Staccato(R) Loxapine) Phase 2a Trial Meets Primary Endpoint of 2-Hour Pain Relief in Patients with Migraine Headache
7. MitraClip Device Preliminary Data Suggests Improved Heart Function and Relief from Heart Failure Symptoms in Functional Mitral Regurgitation Patients
8. invivodata Captures Symptom Relief Data in Endometriosis Trial
9. CIMZIA(R) (Certolizumab Pegol) Provides Rapid and Sustained Relief from Signs and Symptoms of Rheumatoid Arthritis for Two Years
10. FDA Approves Tapentadol Immediate-Release Tablets for Relief of Moderate to Severe Acute Pain
11. Study of Cannabinoid Medicine for Pain Found Patients Got High, but Effects Not Related to Pain Relief
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2017)... , April 19, 2017 ... stimulate an immune response in pets such as ... products are of various types such as Attenuated ... Toxoid Vaccines, DNA Vaccines and Recombinant Vaccines. Attenuated ... as virus or bacteria, which have been weakend ...
(Date:4/19/2017)... April 19, 2017  Novartis today announced the ... Heart, Lung, and Blood Institute (NHLBI) of the ... of patients with treatment-naïve severe aplastic anemia (SAA) ... with eltrombopag at the initiation of and concurrently ... evaluated three sequential treatment groups, or cohorts. Cohort ...
(Date:4/18/2017)... , April 18, 2017  Cardinal Health (NYSE: ... fiscal 2017 earnings per share (EPS) guidance and ... This is in conjunction with this morning,s announcement of ... Thrombosis and Nutritional Insufficiency businesses. Cardinal Health ... operations will be at the bottom of its previous ...
Breaking Medicine Technology:
(Date:4/25/2017)... , ... April 25, 2017 , ... Back Pain ... and back pain with a reputable physician in their area, announces the launch of ... patient information for patients who are looking for reputable physicians to help them with ...
(Date:4/25/2017)... ... April 25, 2017 , ... Saad B. Chaudhary, MD is committed to providing the highest quality ... problems, I focus on preventative care with all my patients to alleviate possible future issues. ... feel free to contact my office and my trained staff will assist you in any ...
(Date:4/25/2017)... ... ... Emergency Physician and Distinguished Professor of Emergency Medicine Bentley Bobrow will be featured ... publish in summer 2017. , Dr. Bobrow, MD, FACEP, FAHA, is an Emergency ... He also serves as Medical Director for the Bureau of Emergency Medical Services and ...
(Date:4/25/2017)... ... , ... Vetoquinol USA® , a world-class developer of ... the EQUISTRO line, at this week’s Rolex Kentucky Three-Day Event in Lexington. Flexadin ... , The scientifically-developed Flexadin UCII supports the body’s normal repair of cartilage and ...
(Date:4/24/2017)... Massachusetts (PRWEB) , ... April 24, 2017 , ... ... will help busy nursing professionals advance their careers. Beginning in the fall of 2017, ... Nursing (BSN) degree in as few as 16 months and for as little as ...
Breaking Medicine News(10 mins):